Evaluation of Postoperative Nutrition Support with Commercial Peripheral Parenteral Nutrition after an Ivor-Lewis Esophagectomy in Patients with Esophageal Cancer.
- Author:
Sun Woo LEE
1
;
Na Ri LIM
;
Hyo Jung PARK
;
Yong Won IN
;
Jeong Meen SEO
;
Young Mee LEE
Author Information
- Publication Type:Original Article
- Keywords: Esophageal neoplasm; Postoperative,; Parenteral nutrition
- MeSH: Body Weight; Calcium; Electronic Health Records; Esophageal Neoplasms*; Esophagectomy*; Fasting; Gastrointestinal Neoplasms; Humans; Incidence; Length of Stay; Magnesium; Male; Malnutrition; Nutritional Status; Parenteral Nutrition*; Phlebitis; Prealbumin
- From:Journal of Clinical Nutrition 2015;7(3):87-92
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: Deteriorated nutritional status is common during a hospital stay for esophagectomy in patients with esophageal cancer. Malnutrition in those patients is often marked compared with other gastrointestinal cancer. The purpose of this study is to evaluate the appropriateness of commercial peripheral parenteral nutrition (CPPN) use in patients who underwent Ivor-Lewis esophagectomy (I-L op). METHODS: Patients who were provided with CPPN after I-L op were enrolled in this study from January to May 2015. Body weight, height, nutritional status, length of hospital stay, duration of CPPN therapy, and parenteral nutrition (PN) induced complications were assessed, respectively, using electronic medical records. RESULTS: Thirty-nine patients were enrolled. Average age was 65.9 years and 36 patients were male. All patients were provided with the same CPPN. The duration of fasting and CPPN use was 5.8+/-1.4 days and 7.5+/-1.8 days, respectively. Calorie supported by CPPN was 22.6+/-3.5 kcal/kg/day and only 20.5% of patients (n=8) reached the daily target calories. Most frequent PN induced complication was phlebitis which occurred in 8 patients (20.5%). Calcium, magnesium, and transthyretin levels in serum were not monitored during the PN support period. CONCLUSION: The indications for CPPN were appropriate because the fasting duration in patients with I-L op was 5 to 10 days. Although a large portion of patients could not be supplied daily target calories, their nutrition status was not significantly changed on admission and at discharge. We did not find it necessary to individualize PN support for a short period after an I-L op in patients with esophageal cancer. Further study will be needed to determine why the incidence of phlebitis was dominant.
